Intervention Review

Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB

  1. Surendra K Sharma1,*,
  2. Anju Sharma2,
  3. Tamilarasu Kadhiravan3,
  4. Prathap Tharyan4

Editorial Group: Cochrane Infectious Diseases Group

Published Online: 5 JUL 2013

Assessed as up-to-date: 15 MAY 2013

DOI: 10.1002/14651858.CD007545.pub2

How to Cite

Sharma SK, Sharma A, Kadhiravan T, Tharyan P. Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB. Cochrane Database of Systematic Reviews 2013, Issue 7. Art. No.: CD007545. DOI: 10.1002/14651858.CD007545.pub2.

Author Information

  1. 1

    All India Institute of Medical Sciences, Department of Medicine, New Delhi, India

  2. 2

    Indian Council of Medical Research, Division of Publication & Information, New Delhi, India

  3. 3

    Jawaharlal Institute of Postgraduate Medical Education and Research, Department of Medicine, Puducherry, India

  4. 4

    Christian Medical College, South Asian Cochrane Network & Centre, Prof. BV Moses & ICMR Advanced Centre for Research & Training in Evidence Informed Health Care, Vellore, Tamil Nadu, India

*Surendra K Sharma, Department of Medicine, All India Institute of Medical Sciences, Room 3097, Teaching Block, Ansari Nagar, New Delhi, 110029, India. sksharma.aiims@gmail.com. sksharma@aims.ac.in.

Publication History

  1. Publication Status: New
  2. Published Online: 5 JUL 2013

SEARCH